SMA Enrichment Daytona

SMA Enrichment Daytona is an addiction-treatment facility located in Daytona Beach, FL. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at SMA Enrichment Daytona

The care-level question matters because what a facility offers is what it can realistically treat well. SMA Enrichment Daytona is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether SMA Enrichment Daytona's offerings match the clinical need.

Insurance and payment

On insurance specifically: SMA Enrichment Daytona accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders, Persons 18 and older with serious mental illness (SMI). The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Before admission to SMA Enrichment Daytona, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether SMA Enrichment Daytona offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.